Neuromodulation and the pudendal nerve

Similar documents
Posterior Tibial Nerve Stimulation

MEDICAL POLICY SUBJECT: PERCUTANEOUS POSTERIOR TIBIAL NERVE STIMULATION (PPTNS) POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: PERCUTANEOUS POSTERIOR TIBIAL NERVE STIMULATION (PPTNS)

Sacral neuromodulation for lower urinary tract dysfunction

Sacral Neuromodulation Beyond Pelvic Pain!!!

NEUROMODULATION FOR UROGYNAECOLOGISTS

Sacral nerve stimulation in patients with detrusor overactivity

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Corporate Medical Policy

Refractory Lower Urinary Tract Symptoms

Neuromodulation for pelvic floor dysfunctions: exploring tibial, sacral and pudendal nerve stimulation. W18, 15 October :00-17:00

Neuro-urology for the Urogynaecologist and urologist W20, 15 October :00-18:00

Neuromodulation for pelvic floor dysfunctions: exploring tibial, sacral and pudendal nerve stimulation. W3, 29 August :00-12:00

Posterior Tibial Nerve Stimulation for Treating Neurologic Bladder in Women: a Randomized Clinical Trial

Technologies and architectures" Stimulator, electrodes, system flexibility, reliability, security, etc."

AUAUpdateSeries. Lesson 19 Volume Treatment of Non-Neurogenic Overactive Bladder with Electrical Stimulation

Expanding the Role of Neuromodulation for Overactive Bladder: New Indications and Alternatives to Delivery

2/5/2016. Evolving Surgical Treatment Approaches for Fecal Incontinence in Women: An Evidence and Cased-Based Approach

Kathleen C. Kobashi, MD, FACS Head, Section of Urology and Renal Transplantation Virginia Mason Medical Center, Seattle, WA

Electrostimulation Part 3: Bladder dysfunctions

Management, Evaluation, and Treatment of Overactive Bladder and Urinary Incontinence

Updates in the nonpharmacological. treatment on overactive bladder

GBM8320 Dispositifs Médicaux Intelligents. Electrostimulation. Part 3: Bladder dysfunctions

Sacral neuromodulation (SNM), using permanent foramen S3 electrode, Early versus late treatment of voiding dysfunction with pelvic neuromodulation

Urogynecology Office. Can You Hold? An Update on the Treatment of OAB. Can You Hold? Urogynecology Office

Vague symptoms. Unexpected flares.

Description. Section: Surgery Effective Date: October 15, 2014 Subsection: Surgery Original Policy Date: December 6, 2012 Subject:

Applications of Neuromodulation of the Lower Urinary Tract in Female Urology

Subject: Percutaneous Tibial Nerve Stimulation

Sacral neurostimulation for urinary retention: 10-year experience from one UK centre

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

SACRAL NEUROMODULATION: EVOLUTION OVER TIME

Stimulation of the Sacral Anterior Root Combined with Posterior Sacral Rhizotomy in Patients with Spinal Cord Injury. Original Policy Date

Sacral Neuromodulation for Refractory Lower Urinary Tract Dysfunction: Results of a Nationwide Registry in Switzerland

2/9/2008. Men Women. Prevalence of OAB. Men: 16.0% Women: 16.9% Prevalence (%) < Age (years)

Satisfaction and Patient Experience With Sacral Neuromodulation: Results of a Single Center Sample Survey

Interventional Treatments for Pelvic Pain

Botulinum Toxin: Applications in Urology

GI Physiology - Investigating and treating patients with pelvic floor dysfunction. Lynne Smith Department of GI Physiology NGH Sheffield

Sacral Nerve Neuromodulation/Stimulation

Percutaneous Tibial Nerve Stimulation

OHTAC Recommendation

MEDICAL POLICY SUBJECT: SACRAL NERVE STIMULATION

INJINTERNATIONAL. Radiographic Position of the Electrode as a Predictor of the Outcome of InterStim Therapy. Original Article INTRODUCTION

Medical Policy. Description/Scope. Position Statement. Rationale

Contrasting the Percutaneous Nerve Evaluation Versus Staged Implantation in Sacral Neuromodulation

Enrico Finazzi-Agrò,*, Filomena Petta, Francesco Sciobica, Patrizio Pasqualetti, Stefania Musco and Pierluigi Bove

Second-line Treatment for OAB

FEP Medical Policy Manual

Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS

Percutaneous Tibial Nerve Stimulation

Index. Note: Page numbers of article titles are in boldface type.

Functional anatomy of the female pelvic floor and lower urinary tract Stefano Floris, MD, PhD Department of Obstetrics and Gynaecology

LUTS after TURP: How come and how to manage? Matthias Oelke

Dana Alrafaiah. - Amani Nofal. - Ahmad Alsalman. 1 P a g e

MEDICAL POLICY SUBJECT: SACRAL NERVE STIMULATION. POLICY NUMBER: CATEGORY: Technology Assessment

Urodynamic outcome of parasacral transcutaneous electrical neural stimulation for overactive bladder in children

Coding for Sacral Neuromodulation

Sacral Nerve Neuromodulation/Stimulation

Mr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.

Name of Policy: Posterior Tibial Nerve Stimulation for Voiding and Sexual Dysfunction

Sacral Neuromodulation for Dysfunctional Voiders Workshop 1 Monday, August 23, 09:00 10:30

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

03/13/18. A. Symptoms lasting for greater than or equal to 12 months that have resulted to significant impairment in activities of daily living; and

25-Feb-16 MANAGEMENT OF URINARY INCONTINENCE IN WOMEN.

Sacral Nerve Neuromodulation/Stimulation. Description

OVERACTIVE BLADDER (OAB)

Sacral Nerve Neuromodulation/Stimulation. Description

Sacral, ilioinguinal, and vasal nerve stimulation for treatment of pelvic, sacral, inguinal and testicular Pain.

A70.4 Insertion of neurostimulator electrodes into peripheral nerve Z12.2 Posterior tibial nerve R15.X Faecal incontinence

NEUROGENIC BLADDER. Dr Harriet Grubb Dr Alison Seymour Dr Alexander Joseph

Percutaneous Tibial Nerve Stimulation

Clinical Policy: Posterior Tibial Nerve Stimulation for Voiding Dysfunction Reference Number: CP.MP.133

The Presence of Fowler s Syndrome Predicts Successful Long-Term Outcome of Sacral Nerve Stimulation in Women with Urinary Retention

Long Term Results of Neuromodulation by Sacral Nerve Stimulation for Lower Urinary Tract Symptoms: A Retrospective Single Center Study

PERCUTANEOUS TIBIAL NERVE STIMULATION

Caudal Neuromodulation with the Transforaminal Sacral Electrode (InterStim R ): Experience in a Pain Center Regarding 12 Implants

What is on the Horizon in Drug Therapy for OAB?

Percutaneous Tibial Nerve Stimulation

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Percutaneous Tibial Nerve Stimulation. Description

Sacral Nerve Neuromodulation/Stimulation for Pelvic Floor Dysfunction

Urodynamic Results of Sacral Neuromodulation Correlate with Subjective Improvement in Patients with an Overactive Bladder

SACRAL NERVE STIMULATION FOR EXPERIENCE IN CHILDREN

Clinical Policy: Posterior Tibial Nerve Stimulation for Voiding Dysfunction

New PercutaneousTechnique of Sacral Nerve Stimulation Has High Initial Success Rate: Preliminary Results

URINARY INCONTINENCE

Various Types. Ralph Boling, DO, FACOG

Neurourology and Urodynamics 34: (2015)

University College Hospital at Westmoreland Street. Percutaneous Tibial Nerve Stimulation (PTNS)

nerve blocks in the diagnosis and therapy of visceral disease

Pathogenesis of Chronic Pelvic Pain

Objectives. Prevalence of Urinary Incontinence URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS

historical perspective 78 outcomes 81 rationale 78 technique 79 81

Medical Policy. MP Percutaneous Tibial Nerve Stimulation

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Percutaneous Tibial Nerve Stimulation Corporate Medical Policy

Advances in Neuromodulation for Bowel Dysfunction - Opening New Frontiers

3/20/10. Prevalence of OAB Men: 16.0% Women: 16.9% Prevalence of OAB with incontinence (OAB wet) Men: 2.6% Women: 9.3% Dry. Population (millions) Wet

Clinical Policy: Urinary Incontinence Devices and Treatments

Transcription:

Neuromodulation and the pudendal nerve Stefan De Wachter, MD, PhD, FEBU Professor of Urology University of Antwerpen, Belgium Chairman dept of Urology, UZA

Disclosures Consultant speaker: Astellas, Medtronic, Axonics, Allergan, Lilly, Solace, Pfizer, Menarini Research grants: Astellas, Medtronic

Neuromodulation and the pudendal nerve What is neuromodulation? Does neuromodulation work for pudendal neuralgia? Rationale to consider neuromodulation Current evidence

What is neuromodulation? Spinal cord stimulation Neuromodulation is any action that changes/modulates pre-existing neural activity Sacral to influence the physiological behavior of an organ Tibial neurostimulation è direct effect (SARS Brindley) Pudendal Electrical chemical magnetic stimulus Sacral Pudendal Tibial Nerve Stimulation Botulinum toxin Perineal Trans sacral

Neuromodulation and the pudendal nerve What is neuromodulation? Does neuromodulation work for pudendal neuralgia? Rationale to consider neuromodulation Current evidence

Why could it be considered as treatment or adjunct Sacral Pudendal Tibial (Spinal cord)

Why could it be considered as treatment or adjunct Sacral Pudendal Tibial

Presacral plexus Sensory nerves S2, S3 Cutaneous branches buttock, thigh Pudendal S2, S3, S4 Sensory to genitalia Muscular branches perineal muscles, external urethral and anal sphincter Pelvic splanchnic S2, S3, S4 Pelvic viscera via hypogastric and pelvic plexus Motor nerves S3, S4 Levator ani and coccygeus muscle From Grants Atlas of Anatomy

Proper Tined Lead Placement ² Following natural nerve path ² Appropriate responses on all electrodes ² Motor response under 2 V

Acute S3 stimulation Sensory response Motor response Anal wink No direct motor contraction Reflex mediated contraction Early late component Pudendal afferent Survives spinalization Schurch et al. World J Urol 20(6):319,322, 2003

Chronic S3 stimulation Modulates pudendal afferent transmission Malaguti et al. J Urol 170:2323-2326,2003

Sacral neuromodulation Conventional indications / Experimental Overactive bladder symptoms Urgency Incontinence Urinary retention Faecal incontinence Constipation Pelvic pain Sexual dysfucntion

Longterm Results Conventional indications Prospective ww, multicenter - 5 year FU 152 pt s: 96 UUI (63.2%) 25 (16.4%) urgency-frequency and 31 (20.4%) urinary retention 105 pt s had 5 year data There was a high correlation between 1- and 5-year success rates: 84% of patients with UUI, 71% with UF and 78% with UR who were successfully treated at 1 year continued to have a successful outcome after 5 years Mean number AE resulting in surgical intervention occurred respectively in 19.9% and 39.5% of patients at 1-year and 5-year follow-up Van Kerrebroeck et al. J Urol 178:2029-2034, 2007

Current scientific data Sacral neuromodulation and pelvic pain Everaert et al. 2001 Chronic pelvic pain excluding IC/BPS (n=26) significant pain relief in 62% (n=16) 42% received implant (n=11) 36mo FU 73% satisfied with treatment (n=8)

Current scientific data Sacral neuromodulation and pudendal neuralgia Only 1 case reports available Robotic assisted radical hysterectomy right side Nantes criteria positive Positive response nerve blocks / local anesthetics pudendal nerve Bilateral S3 S4 lead ultra pulse generator Successful outcome 4y FU

Why could it be considered as treatment or adjunct Sacral Pudendal Tibial

Extrapelvic stimulation

Pudendal nerve stimulation Peters KM et al. Neurourol Urodyn. 2005;24:643-647. Spinelli M, et al. Neurourol Urodyn. 2005;24(4):305-9.

Pudendal nerve stimulation Final placement of electrodes

Pudendal nerve stimulation Results conventional indications Peters et al. Neurourol Urodyn 24: 643-647, 2005; Peters et al. Neurourol Urodyn 29: 1267-1271, 2010 Sacral vs Pudendal nerve Stimulation 30 patients with both leads PNS è 63% improvement in complaints SNS è 46% improvement in complaints 79% chose pudendal over sacral stimulation 93% sacral failures respond to pudendal 17/30 (57%) with pelvic pain showed marked improvement in pain

Current scientific data Pudendal neuromodulation and pudendal neuralgia Carmel et al. Int Urogynecol 2010 3 patients fulfilled Nantes Criteria Case 1: 64y female >30y ss/ - Pain reduction 80% - FU 2 years Burning pain genitalia, perineum and rectum Case 2: 44y female ; > 7y ss/ - nearly painfree FU 2 years Burning sensation anus and left buttock Case 3: 43y female ; > 20y ss/ - Pain reduction >80% FU 2 years

Current scientific data Pudendal neuromodulation and pudendal neuralgia Peters et al. LUTS 2015 19 patients pudendal neuralgia retrospectively reviewed 55y age 18/19 already had nerve blocks 15/18 experienced some relief 19/19 successful test IPG implanted 3 complete relief / 3 almost complete / 10 significant / 3 small relief 5 explanted after 3 years

20 patients with CPPS >3/5 Nantes criteria not mentioned how many

Why it could be considered as treatment or adjunct Sacral Pudendal Tibial

Procedure Tibial nerve sends afferents through the sacral nerve plexus Studied since the 1980 s for the treatment of OAB

Peters et al. J Urol 183: 1438, 2010 SUmiT trial Sham controlled trial Endpoint GRA Moderate improvement

Peters et al. J Urol 189: 2194-2201, 2013 STEP study 36 mo results following SUmiT 60 responders SUmiT eligible 50 consented to study 29 (58%) completed 36 mo (=26% of initial 110 patients) Treatment schedule tailored to patient s need Endpoint GRA moderate improvement 97% 76% 12 months 43 47 7 24 months 40 46 14 36 months 45 41 14 0% 20% 40% 60% 80% 100%

Istek et al. Arch Gynecol Obstet 290: 291-298, 2014 Current scientific data Tibial nerve stimulation and chronic pelvic pain RCT 16 PTNS vs 17 control Chronic pelvic pain excluding IC/PBS PTNS 2/16 (13%) cured 7/16 (44%) improved P<0.05 Control 2/17 (12%) improved Present Pain Intensity VAS 9 8 7 6 5 4 3 2 1 0 PTNS Control Baseline 12w 6mo

Implantable tibial nerve stimulation

Neuromodulation and the pudendal nerve What is neuromodulation? Does neuromodulation work for pudendal neuralgia? Rationale to consider neuromodulation Current evidence Currently only limited data available Pudendal neuromodulation seems most promising Lots of questions to be answered Monotherapy or adjunct therapy? Standardized placement electrodes? Longterm effect?

Thank you for listening